16-gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes

Ophthalmic Surgery Lasers and Imaging

Volumn 42, Issue 6, 2011, Pages 468-473

  Canton, Virgilio Morales ^a   Quiroz Mercado, Hugo ^a,b   Velez Montoya, Raul ^a,b   Lopez Miranda, Miriam J ^a   Moshfeghi, Andrew A ^c   Shusterman, Eugene M ^d   Kaiser, Peter K ^e   Sanislo, Steven R ^f   Gertner, Michael ^d   Moshfeghi, Darius M ^f  

^a IAP ^*  (Mexico)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Oraya Therapeutics Inc   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; X IRRADIATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; VISUAL ACUITY;

EID: 83055195175     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20110804-01     Document Type: Article

References (43)

1. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol. 1993;77:265-273. (Pubitemid 23177354)
2. Chakravarthy U, MacKenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol. 2000;73:305-313. (Pubitemid 30192804)
3. Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2010;(5):CD004004.
4. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol. 1999;127:170-177. (Pubitemid 29072557)
5. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology. 1996;103:878-889. (Pubitemid 26190720)
6. Finger PT, Gelman YP, Berson AM, Szechter A. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol. 2003;87:1497-1503. (Pubitemid 38010556)
7. Flaxel CJ, Friedrichsen EJ, Smith JO, et al. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration. Eye. 2000;14:155-164. (Pubitemid 30265161)
8. Jaakkola A, Heikkonen J, Tarkkanen A, Immonen I. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization. Acta Ophthalmol Scand. 1999;77:57-61. (Pubitemid 29057489)
9. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1998;236:24-30. (Pubitemid 28080567)
10. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology. 2005;112:567-573. (Pubitemid 41108854)
11. Jaakkola A, Tommila P, Laatikainen L, Immonen I. Grading choroidal neovascular membrane regression after strontium plaque radiotherapy; masked subjective evaluation vs planimetry. Eur J Ophthalmol. 2001;11:269-276. (Pubitemid 33042279)
12. Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2004;(18):CD004004.
13. Zambarakji HJ, Lane AM, Ezra E, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006;113:2012-2019. (Pubitemid 44635705)
14. Adams JA, Paiva KL, Munzenrider JE, Miller JW, Gragoudas ES. Proton beam therapy for age-related macular degeneration: development of a standard plan. Med Dosim. 1999;24:233-238.
15. Avila MP, Farah ME, Santos A, Duprat JP, Woodward BW, Nau J. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol. 2009;93:305-309.
16. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina. 2009;29:157-169.
17. Gertner M, Chell E, Pan KH, Hansen S, Kaiser PK, Moshfeghi DM. Stereotactic targeting and dose verification for age-related macular degeneration. Med Phys. 2010;37:600-606.
18. Taddei P, Chell E, Hansen S, Gertner M, Newhauser W. Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration. Phys Med Biol. 2010;55:7037-7054.
19. Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol. 2011;95:185-188.
20. Lee C, Chell E, Gertner M, et al. Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration. Med Phys. 2008;35:5151-5160.
21. Hanlon J, Lee C, Chell E, et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys. 2009;36:3671-3681.
22. Holmes SM, Micka JA, DeWerd LA. Investigation of a 90Sr/90Y source for intraocular treatment of wet age-related macular degeneration. Med Phys. 2009;36:4370-4378.
23. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:755-763. (Pubitemid 24355922)
24. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:765-773. (Pubitemid 24355923)
25. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology (Williston Park). 1996;10:837-847. (Pubitemid 126520853)
26. Parsons JT, Fitzgerald CR, Hood CI, Ellingwood KE, Bova FJ, Million RR. The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys. 1983;9:609-622. (Pubitemid 13106623)
27. Amoaku WM, Archer DB. Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye. 1990;4:657-667.
28. Berker N, Aslan O, Batman C, Elgin U, Ozkan SS. Choroidal neovascular membrane in radiation retinopathy. Clin Experiment Ophthalmol. 2006;6:625-626.
29. Chee PH. Radiation retinopathy. Am J Ophthalmol. 1968;66:860-865.
30. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol. 1991;112:600-601.
31. Takeda A, Shigematsu N, Suzuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys. 1999;44:599-605. (Pubitemid 29258435)
32. Axer-Siegel R, Kremer I, Ben-Sira I, Weiss J. Radiation retinopathy treated with the krypton red laser. Ann Ophthalmol. 1989;7:272-274, 276.
33. Bakri SJ, Beer PM. Photodynamic therapy for maculopathy due to radiation retinopathy. Eye. 2005;7:795-799. (Pubitemid 41030579)
34. Finger PT, Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol. 2005;89:730-738. (Pubitemid 40780582)
35. Haas A, Pinter O, Papaefthymiou G, et al. Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology. 2002;109:909-913. (Pubitemid 34465224)
36. Hoyng CB, Tromp AI, Meulendijks CFM, et al. Side effects after radiotherapy of age-related macular degeneration with the Nijmegen technique. Graefes Arch Clin Exp Ophthalmol. 2002;240:337-341. (Pubitemid 36075606)
37. Kreusel KM, Bornfeld N, Lommatzsch A, Wessing A, Foerster MH. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998;105:1386-1392. (Pubitemid 28509754)
38. Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina. 2007;27:903-907. (Pubitemid 47479385)
39. Mauget-Faÿsse M, Chiquet C, Milea D, et al. Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol. 1999;83:923-928. (Pubitemid 29376026)
40. Hall EJ, Giaccia AJ. Acute Effects of Total-Body Irradiation: Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2006:117-128.
41. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007;144:627-637.
42. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431. (Pubitemid 44511557)
43. Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of Ranibizumab for neovascular age-related macular degeneration: PIER Study Year 1. Am J Ophthalmol. 2008;145:239-248.